Frontal cortex BDNF levels correlate with working memory in an animal model of Down syndrome

Topic: Disease mechanisms in lab and animal studies

Individuals with Down syndrome (DS) develop most neuropathological hallmarks of Alzheimer's disease early in life, including loss of cholinergic markers in the basal forebrain. Ts65Dn mice, an animal model of DS, perform poorly on tasks requiring spatial memory and also exhibit basal forebrain pathology beginning around 6 months of age. We evaluated memory as well as brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) protein levels in basal forebrain, frontal cortex, hippocampus, and striatum in Ts65Dn mice at the age when cholinergic degeneration is first observed, and compared values to normosomic controls. Six-month-old Ts65Dn mice exhibited impairments in working and reference memory as assessed on a water radial-arm maze. The working memory deficit was related to the inability of Ts65Dn mice to successfully sustain performance as the working memory load increased. Coupled with cognitive performance deficiencies, Ts65Dn mice also exhibited lower frontal cortex BDNF protein levels than controls. Further, BDNF levels were negatively correlated with working memory errors during the latter portion of testing in Ts65Dn mice, thereby suggesting that lower BDNF protein levels in the frontal cortex may be associated with the observed working memory impairment.

Key findings

• Further, BDNF levels were negatively correlated with working memory errors during the latter portion of testing in Ts65Dn mice, thereby suggesting that lower BDNF protein levels in the frontal cortex may be associated with the observed working memory impairment.

Study details

• Evidence strengthLow

Read the original

• DOI: 10.1016/s0166-4328(02)00082-7
• PubMed: 12642175
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

@article{bimontenelson2003-12642175,
  author  = {Bimonte-Nelson, H. A. and Hunter, C. L. and Nelson, M. E. and Granholm, A. C.},
  title   = {{Frontal cortex BDNF levels correlate with working memory in an animal model of Down syndrome}},
  journal = {Behavioural brain research},
  year    = {2003},
  doi     = {10.1016/s0166-4328(02)00082-7},
  pmid    = {12642175},
  url     = {https://doi.org/10.1016/s0166-4328(02)00082-7}
}

Related studies in Down syndrome and Alzheimer's

• Learning and memory as a function of age in Down syndrome: a study using animal-based tasks Progress in neuro-psychopharmacology & biological psychiatry · 2005-03-01 · usefulness score 45/100
• Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease Acta neurologica Scandinavica · 1997-10-01 · usefulness score 36/100
• Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome Biochimica et biophysica acta · 2011-10-08 · usefulness score 47/100
• Down syndrome: age-dependence of PiB binding in postmortem frontal cortex across the lifespan Neurobiology of aging · 2017-03-14 · usefulness score 43/100
• Polyamines in frontal cortex of patients with Down syndrome and Alzheimer disease Neuroscience letters · 1996-03-01 · usefulness score 37/100
• Endogenous opioids in frontal cortex of patients with Down syndrome Neuroscience letters · 1996-01-01 · usefulness score 33/100

Also tagged “dosage”

80 studies in the library carry the topic tag “dosage”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 80 tagged studies.

• Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer's Disease Free radical biology & medicine · 2017-10-06 · usefulness score 38/100 · Down syndrome and Alzheimer's
• Beta amyloid gene duplication in Alzheimer's disease and karyotypically normal Down syndrome Science (New York, N.Y.) · 1987-03-01 · usefulness score 41/100 · Down syndrome and Alzheimer's
• Down syndrome and Alzheimer's disease: Common pathways, common goals Alzheimer's & dementia : the journal of the Alzheimer's Association · 2014-12-12 · usefulness score 52/100 · Down syndrome and Alzheimer's

Similar studies

• Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome 2014 · Down syndrome and Alzheimer's
• Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease 2009 · Down syndrome and Alzheimer's
• Perinatal choline supplementation improves cognitive functioning and emotion regulation in the Ts65Dn mouse model of Down syndrome 2010 · Down syndrome and Alzheimer's
• Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome 2013 · Down syndrome and Alzheimer's
• Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential 2022 · Disease mechanisms
• Neurological phenotypes for Down syndrome across the life span 2012 · Digital health tools

More on Down syndrome and Alzheimer's

• A review that covers this ground Glucose, memory, and aging The American journal of clinical nutrition · 1998-04-01 · usefulness score 40/100
• Newest in this subject Differential endothelial cell remodeling in Down syndrome and APP duplication drives distinct blood brain barrier dysfunction bioRxiv · 2026-10-30 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Memory and Plasma pTau217 Refine Prognosis in Down Syndrome Annals of neurology · 2026-10-02 · Peer-reviewed · usefulness score 47/100

See all studies in Down syndrome and Alzheimer's →